Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1791
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV